Tests a low protein diet to help protect kidneys in chronic kidney disease
Tests a low protein diet to slow kidney decline in adults with chronic kidney disease.
Plain-language title generated from the registry record
Registry title: Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach
Key facts
- Where
- La Flèche and Le Mans, FranceSee the 2 sites
Where in France
- Pôle Santé Sarthe et LoirLa Flèche, FranceTaking people
- Centre Hospitalier Le MansLe Mans, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Hospitalier le Mans
- Trial code
- NCT03979534
- Record updated
- 1 July 2026
- Original description
Nephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need for renal replacement therapy, but the best diet to be prescribed is still matter of discussion. This study is aimed at identifying implementation strategies for nutritional management of advanced CKD.Read full original descriptionShow less
Protecting Kidneys Through a Low Protein Diet: A Stepwise Multiple-Choice System Approach
Nephrology care continues to progress and recommendations are now focused on delaying as much as possible the need for renal replacement therapy ("intent-to-defer"strategy). Protein restriction is a valuable tool for stabilizing chronic kidney disease (CKD) and retarding the need for renal replacement therapy, but the best diet to be prescribed is still matter of discussion. This study is aimed at identifying implementation strategies for nutritional management of advanced CKD.
Inclusion: All adult patients followed on the unit for advanced CKD, with Kidney disease stage 4-5 or stage 3 with fast progression and without contraindications.
Exclusion: Patients aged less than 18 years old; Malnutrition or short life-expectancy; Pregnant women,; Incapacity to complete the free-consent form,; Pateints refusing participation in the study,; Patients without healthcare coverage.